GO:2000765 regulation of cytoplasmic translation: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000765 regulation of cytoplasmic translation describes any process that modulates the frequency, rate or extent of translation in the cytoplasm, the central step of protein synthesis in eukaryotic cells.
• The mTORC1 pathway is a master regulator of cytoplasmic translation, controlling initiation and elongation through phosphorylation of 4E-BP1 and S6K1.
• Ribosome heterogeneity, including site-specific rRNA methylation and differential ribosomal protein composition, fine-tunes which mRNAs are translated.
• Cytoplasmic translation is also regulated by non-canonical RNAs such as circular RNAs and by metabolic inputs like one-carbon metabolism.
• Dysregulation of cytoplasmic translation is linked to cancer, neurodegeneration, and ribosomopathies, making it a key area for therapeutic targeting.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of regulatory nodes in cytoplasmic translation.
Description
Regulation of cytoplasmic translation (GO:2000765) encompasses all cellular processes that control the frequency, rate, or extent of protein synthesis occurring in the cytoplasm. This regulation is essential for maintaining proteostasis, responding to environmental cues, and executing developmental programs. In eukaryotic cells, the majority of translation occurs in the cytoplasm, where ribosomes decode messenger RNAs (mRNAs) into polypeptides. The mTORC1 signaling pathway integrates nutrient and growth factor signals to modulate translation initiation and elongation, primarily through phosphorylation of downstream effectors such as 4E-BP1 and S6K1. Beyond canonical initiation factors, emerging evidence highlights the role of ribosome heterogeneity, including site-specific ribosomal RNA methylation and differential ribosomal protein composition, in selectively translating distinct mRNA subpools. Additionally, non-coding RNAs like circular RNAs can be translated in a cap-independent manner, further expanding the regulatory landscape. Understanding these mechanisms is critical for researchers studying cancer, metabolic disorders, and neurological diseases, where translation dysregulation is a common hallmark.
regulation of cytoplasmic translation At A Glance
| GO ID | GO:2000765 |
|---|---|
| GO term | regulation of cytoplasmic translation |
| Ontology | biological_process |
| Synonym | None |
| Major function | Modulates the frequency, rate, or extent of protein synthesis in the cytoplasm |
| Related processes | mTORC1 signaling, ribosome biogenesis, mRNA stability, translation initiation and elongation |
| Key regulators | mTORC1, 4E-BP1, S6K1, ribosomal RNA methylation, circular RNAs |
| Disease relevance | Cancer, neurodegeneration, ribosomopathies, metabolic disorders |
What Is GO:2000765?
According to the Gene Ontology, GO:2000765 (regulation of cytoplasmic translation) is defined as any process that modulates the frequency, rate or extent of cytoplasmic translation. This term is a biological process and does not have synonyms in the QuickGO database. It specifically refers to the regulation of translation that takes place in the cytoplasm, distinguishing it from mitochondrial or chloroplast translation.
Why Is regulation of cytoplasmic translation Important in Cell Biology?
Regulation of cytoplasmic translation is fundamental to cellular adaptation and survival. It allows cells to rapidly alter protein production in response to nutrients, stress, and growth signals, thereby controlling cell growth, proliferation, and differentiation. Dysregulation of this process contributes to a wide range of human diseases, including cancer, where aberrant translation drives oncogenic transformation, and neurodegenerative disorders, where impaired translation leads to protein aggregation and neuronal death. Moreover, understanding cytoplasmic translation regulation provides opportunities for therapeutic intervention, as many signaling pathways and RNA-binding proteins involved are druggable targets.
• Controls protein synthesis rates in response to nutrient and energy status via mTORC1.
• Regulates cell cycle progression and proliferation, with implications for cancer therapy.
• Modulates synaptic plasticity and memory formation through local translation in neurons.
• Influences immune cell activation and cytokine production.
• Plays a role in viral replication by controlling translation of viral mRNAs.
• Affects stem cell self-renewal and differentiation.
• Contributes to metabolic reprogramming in cancer cells.
• Involved in stress granule formation and mRNA storage.
• Dysregulated in ribosomopathies such as Diamond-Blackfan anemia.
• Target for small molecule inhibitors in cancer and metabolic diseases.
What Happens During regulation of cytoplasmic translation?
Initiation Control by mTORC1 Signaling
In simple terms: mTORC1 acts like a switch that turns protein production on or off based on nutrient availability.
The mTORC1 kinase integrates growth factor and nutrient signals to regulate translation initiation. It phosphorylates 4E-BP1, causing it to release eIF4E, which then assembles with eIF4G and eIF4A to form the eIF4F complex on the 5' cap of mRNAs. This step is rate-limiting for cap-dependent translation. Additionally, mTORC1 phosphorylates S6K1, which promotes translation elongation and ribosome biogenesis.
Ribosome Heterogeneity and Specialized Translation
In simple terms: Not all ribosomes are the same; some have chemical tags that make them prefer certain mRNAs.
Ribosomes can vary in their ribosomal RNA methylation and protein composition, leading to preferential translation of distinct mRNA subpools. For example, site-specific methylation of 28S rRNA by METTL5 or ZCCHC4 affects translation of specific mRNAs involved in cell cycle and metabolism. Heterogeneous ribosomes containing RPS25 or RPL10A paralogs translate different sets of mRNAs, influencing cell fate decisions.
Regulation by Non-coding RNAs and Circular RNAs
In simple terms: Some circular RNAs can be translated into proteins, adding another layer of control.
Circular RNAs (circRNAs) are generated by back-splicing and can contain internal ribosome entry sites (IRES) or N6-methyladenosine (m6A) modifications that recruit ribosomes for cap-independent translation. This process is regulated by factors such as eIF4G2 and m6A reader YTHDF3, and can produce proteins with distinct functions from their linear counterparts.
Metabolic Regulation via One-Carbon Metabolism
In simple terms: Vitamins like folate provide chemical building blocks that influence how efficiently proteins are made.
One-carbon metabolism, involving folate and methionine cycles, supplies methyl groups for tRNA and rRNA methylation, which are critical for translation fidelity and efficiency. In bacteria and eukaryotic organelles, this regulation links nutrient availability to protein synthesis rates.
ERK1/2 Signaling in Oocyte Meiosis
In simple terms: ERK1/2 kinases help control protein production during egg cell division.
During oocyte meiosis, the ERK1/2 pathway regulates translation of stored maternal mRNAs, which is essential for meiotic progression and maturation. This regulation involves phosphorylation of translation initiation factors and RNA-binding proteins, ensuring timely protein synthesis.
Key Genes Involved in GO:2000765 regulation of cytoplasmic translation
The following genes and proteins are key players in the regulation of cytoplasmic translation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Kinase that phosphorylates 4E-BP1 and S6K1 to promote translation initiation and elongation | Central regulator; target of rapamycin inhibitors in cancer and transplantation |
| EIF4EBP1 | Repressor of eIF4E; phosphorylation by mTORC1 relieves inhibition | Biomarker for mTORC1 activity; knockout models show increased translation |
| RPS6KB1 | Kinase that phosphorylates ribosomal protein S6 to enhance translation | Target for metabolic and cancer studies |
| EIF4E | Cap-binding protein that initiates translation | Overexpressed in cancers; target for antisense oligonucleotides |
| METTL5 | Methyltransferase that deposits m6A on 28S rRNA | Regulates ribosome heterogeneity and specific mRNA translation |
| ZCCHC4 | rRNA methyltransferase that modifies 28S rRNA | Impacts translation of mRNAs involved in proliferation |
| RPS25 | Ribosomal protein paralog that affects translation of specific mRNAs | Knockout alters translation of viral and cellular mRNAs |
| RPL10A | Ribosomal protein paralog with specialized translation functions | Involved in translating mRNAs with specific motifs |
| EIF4G2 | Translation initiation factor for cap-independent translation | Required for circRNA translation |
| YTHDF3 | m6A reader that promotes translation of methylated RNAs | Enhances circRNA translation |
| MTHFD1 | Enzyme in one-carbon metabolism | Supplies methyl groups for tRNA/rRNA methylation |
| MTR | Methionine synthase in one-carbon metabolism | Links folate cycle to translation |
| MAPK1 | ERK2 kinase that regulates translation during meiosis | Required for oocyte maturation |
| MAPK3 | ERK1 kinase that regulates translation during meiosis | Required for oocyte maturation |
| EIF2AK1 | Kinase that phosphorylates eIF2α to inhibit translation under stress | Mediates translational adaptation |
| EIF2S1 | Alpha subunit of eIF2; phosphorylation inhibits initiation | Key node in integrated stress response |
| DCP1A | Decapping enzyme involved in mRNA decay linked to translation defects | Connects translation to mRNA stability |
| XRN1 | Exonuclease that degrades decapped mRNAs | Affects translation-defective mRNA decay |
How Is regulation of cytoplasmic translation Regulated?
Regulation of cytoplasmic translation is orchestrated by multiple signaling pathways and RNA-binding proteins. The mTORC1 pathway is the most prominent, responding to amino acids, glucose, and growth factors to control translation initiation and elongation. The integrated stress response (ISR) kinases, such as PERK and GCN2, phosphorylate eIF2α to globally reduce translation while selectively increasing translation of stress-responsive mRNAs. Additionally, site-specific rRNA methylation by METTL5 and ZCCHC4 modulates ribosome function and mRNA selectivity. Circular RNAs can be translated in a cap-independent manner regulated by m6A modification and eIF4G2. One-carbon metabolism provides methyl donors for tRNA and rRNA modifications, linking nutrient status to translation efficiency. ERK1/2 signaling controls translation during oocyte meiosis. These layers of regulation ensure precise control of protein synthesis in response to cellular demands.
regulation of cytoplasmic translation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Cancer, metabolic disorders | Knockout or point mutation in cancer cell lines; xenograft models |
| EIF4EBP1 | Cancer, translation control | Knockout in HEK293T; overexpression in cancer cells |
| METTL5 | Ribosomopathy, cancer | Knockout in HeLa; point mutation of methyltransferase domain |
| RPS19 | Diamond-Blackfan anemia | Knockout in hematopoietic stem cells; knock-in of patient mutations |
| EIF2AK1 | Neurodegeneration, stress response | Knockout in neuronal cell lines; point mutation of kinase domain |
Cancer
Dysregulated cytoplasmic translation is a hallmark of cancer. Oncogenic activation of mTORC1 leads to hyperactive translation of mRNAs encoding growth factors, cyclins, and anti-apoptotic proteins, driving proliferation and survival. Overexpression of eIF4E and ribosomal proteins is common in many cancers and correlates with poor prognosis. Ribosome heterogeneity, such as altered rRNA methylation, can promote translation of oncogenic mRNAs. Targeting translation regulators, including mTOR inhibitors and eIF4E antisense oligonucleotides, is an active therapeutic strategy.
Neurodegeneration
Impaired regulation of cytoplasmic translation contributes to neurodegenerative diseases. In Alzheimer's disease and amyotrophic lateral sclerosis, stress-induced eIF2α phosphorylation leads to global translation repression and formation of stress granules, which may seed protein aggregates. Dysfunctional local translation at synapses impairs synaptic plasticity and memory. Mutations in ribosomal proteins or translation factors cause ribosomopathies with neurological features.
Ribosomopathies
Ribosomopathies are disorders caused by mutations in ribosomal proteins or assembly factors, leading to defective ribosome biogenesis and translation. Diamond-Blackfan anemia, caused by mutations in RPS19 or RPL5, features impaired erythropoiesis due to reduced translation of key erythroid mRNAs. Shwachman-Diamond syndrome, linked to SBDS mutations, affects translation and causes bone marrow failure. These diseases highlight the importance of precise translation regulation for tissue-specific functions.
Metabolic Disorders
One-carbon metabolism defects, such as methylenetetrahydrofolate reductase (MTHFR) deficiency, impair tRNA and rRNA methylation, leading to translation defects and metabolic imbalances. mTORC1 dysregulation is implicated in obesity, type 2 diabetes, and non-alcoholic fatty liver disease, where aberrant translation contributes to insulin resistance and lipid accumulation.
From regulation of cytoplasmic translation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate global translation rate? | Knockout cell line (e.g., HEK293T) followed by puromycin incorporation assay |
| Does a specific point mutation in mTOR affect substrate specificity? | Point mutation knock-in in cancer cell lines |
| How does a disease-associated mutation in RPS19 affect translation? | Knock-in of patient mutation in hematopoietic cells |
| What is the interactome of eIF4E? | Tagged knock-in of EIF4E with FLAG-HA in HeLa cells |
| Does overexpression of METTL5 alter mRNA translation selectivity? | Overexpression in HEK293T followed by Ribo-seq |
| Can CRISPR library screening identify novel regulators of translation? | Genome-wide knockout library in K562 cells with translation reporter |
How to Study the regulation of cytoplasmic translation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Genome-wide translation efficiency | Identifying differentially translated mRNAs upon gene knockout |
| Polysome profiling | Distribution of mRNAs across polysomes | Validating translation initiation changes |
| Puromycin incorporation | Global protein synthesis rate | High-throughput screening of translation inhibitors |
| Mass spectrometry | Protein abundance and modifications | Proteomic changes after translation perturbation |
| m6A-seq | m6A RNA methylation sites | Mapping rRNA and mRNA methylation |
| CircRNA translation assay | Cap-independent translation of circRNAs | Studying IRES-mediated translation |
| CRISPR screen | Fitness or reporter-based selection | Identifying novel translation regulators |
| Immunofluorescence | Localization of translation factors | Visualizing stress granule formation |
Ribosome Profiling (Ribo-seq)
Ribo-seq provides a genome-wide snapshot of translated mRNAs by sequencing ribosome-protected fragments. It quantifies translation efficiency and identifies differential translation in response to genetic perturbations. This method is essential for studying how knockout or overexpression of regulatory genes affects the translatome.
Polysome Profiling
Polysome profiling separates mRNAs by the number of ribosomes bound, allowing assessment of global translation initiation and elongation rates. It is used to validate Ribo-seq findings and to study the impact of mTOR inhibitors or nutrient deprivation.
Puromycin Incorporation Assay
This assay measures global protein synthesis rates by detecting puromycin-labeled nascent peptides. It is rapid and suitable for high-throughput screening of translation regulators.
Mass Spectrometry-Based Proteomics
Proteomics quantifies changes in protein abundance and post-translational modifications, complementing transcriptomic and translatomic data. It is used to identify downstream effects of translation regulation.
How CRISPR Can Be Used to Study GO:2000765 regulation of cytoplasmic translation
Knockout
CRISPR knockout of genes encoding translation regulators, such as MTOR or EIF4EBP1, allows researchers to assess their necessity for cytoplasmic translation. For example, mTOR knockout reduces phosphorylation of 4E-BP1 and S6K1, leading to decreased translation initiation. Knockout of METTL5 alters rRNA methylation and selectively impairs translation of specific mRNAs.
Point Mutation
Point mutations can be introduced to dissect catalytic activity or phosphorylation sites. For instance, knock-in of kinase-dead mTOR or phospho-deficient 4E-BP1 mutants clarifies the role of specific residues in translation control. Point mutations in ribosomal protein genes, such as RPS19, model ribosomopathy-associated translation defects.
Knock-in
Knock-in of tagged alleles (e.g., FLAG-HA-EIF4E) enables affinity purification and interactome analysis. Knock-in of disease-associated mutations, such as those in RPS19 or EIF2AK1, creates isogenic models to study translation dysregulation in a physiological context.
Overexpression
Overexpression of translation factors or regulators, such as eIF4E or METTL5, can drive oncogenic transformation or alter translatome profiles. CRISPR activation (CRISPRa) allows targeted overexpression to study dosage effects on translation.
How EDITGENE Supports regulation of cytoplasmic translation Research
Researchers studying regulation of cytoplasmic translation-related genes often need to determine whether a candidate gene is causally involved in translation control, and to dissect the precise molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of cytoplasmic translation research.
Frequently Asked Questions About regulation of cytoplasmic translation
What is GO:2000765 regulation of cytoplasmic translation?
GO:2000765 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of cytoplasmic translation.
What genes are involved in regulation of cytoplasmic translation?
Key genes include MTOR, EIF4EBP1, RPS6KB1, EIF4E, METTL5, ZCCHC4, RPS25, RPL10A, EIF4G2, YTHDF3, and others.
How does mTOR regulate cytoplasmic translation?
mTORC1 phosphorylates 4E-BP1 and S6K1 to promote translation initiation and elongation in response to nutrients and growth factors.
What is the role of ribosome heterogeneity in translation?
Ribosome heterogeneity, including rRNA methylation and ribosomal protein paralogs, allows selective translation of distinct mRNA subpools.
Can circular RNAs be translated in the cytoplasm?
Yes, some circular RNAs contain IRES or m6A modifications that enable cap-independent translation.
How is cytoplasmic translation regulated by one-carbon metabolism?
One-carbon metabolism supplies methyl groups for tRNA and rRNA methylation, which are required for efficient translation.
What diseases are associated with dysregulated cytoplasmic translation?
Cancer, neurodegeneration, ribosomopathies, and metabolic disorders are linked to translation dysregulation.
What methods are used to study regulation of cytoplasmic translation?
Ribo-seq, polysome profiling, puromycin incorporation, proteomics, and CRISPR screens are commonly used.
How can CRISPR be used to study translation regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal dissection of regulatory genes.
What services does EDITGENE offer for translation research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
Regulation of cytoplasmic translation (GO:2000765) is a fundamental biological process that controls protein synthesis in response to diverse cellular signals. Its dysregulation underlies numerous human diseases, making it a critical area of research. Advances in CRISPR-based models and high-throughput sequencing technologies are enabling precise dissection of the regulatory networks involved. EDITGENE offers comprehensive services to support these studies, from custom cell model generation to bioinformatics analysis.
References
- 1. Thoreen CC et al.. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation.. Nature 485(7396):109-13 PMID: 22552098
- 2. El-Brolosy MA et al.. 2026. Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation.. Science 391(6786):eaea1272 PMID: 41678638
- 3. Kummer E et al.. 2021. Mechanisms and regulation of protein synthesis in mitochondria.. Nat Rev Mol Cell Biol 22(5):307-325 PMID: 33594280
- 4. Shetty S et al.. 2021. Regulation of translation by one-carbon metabolism in bacteria and eukaryotic organelles.. J Biol Chem 296:100088 PMID: 33199376
- 5. Pamudurti NR et al.. 2017. Translation of CircRNAs.. Mol Cell 66(1):9-21.e7 PMID: 28344080
- 6. Jansson MD et al.. 2021. Regulation of translation by site-specific ribosomal RNA methylation.. Nat Struct Mol Biol 28(11):889-899 PMID: 34759377
- 7. Kalous J et al.. 2018. Importance of ERK1/2 in Regulation of Protein Translation during Oocyte Meiosis.. Int J Mol Sci 19(3) PMID: 29494492
- 8. Shi Z et al.. 2017. Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide.. Mol Cell 67(1):71-83.e7 PMID: 28625553
